Navigation Links
Arsenic May Have Been Responsible For The Madness Of King George III Of England

An interesting study from hair of King George III reveals that he may// have been consuming Arsenic and this lead to his unusually severe and prolonged bouts of madness.

Lancet has published this report this week and at last has been able to throw light on the reason for the madness of the famous English King George III. The study reports to have found high concentrations of arsenic in a sample of King George III’s hair and this may have been the main contributory factor.

Prof. Martin Warren and colleagues investigated exposure of arsenic in a sample of the King’s hair. Professor Warren said: “The presence of arsenic in a sample of the King’s hair provides a plausible explanation for the length and severity of his attacks of illness; and contamination of his antimonial medications is the probable source of the arsenic. We propose that exposure to arsenic would exacerbate attacks of porphyria in a genetically predisposed individual.

King George III was diagnosed to have suffered from Porphyria- a genetic defect leading to the faulty synthesis of a protein. However during his regime he suffered from five major episodes of prolonged and profound mental derangement. The King’s illness was originally thought to be a psychiatric disorder. However, there is little information available to account for the unusual persistence, severity, and late onset of attacks.

When the researchers looked at the Royal physician’s medical notes to try and identify the source of the arsenic; they found that the principal compound administered to the King during his illness was emetic tartar. Emetic tartar contains a substance called antimony, which can be contaminated with arsenic. The authors believe that the King’s medication was the source of the arsenic found in the hair sample.

News Extract - Newswise.
Original Source: Lncet
'"/>




Page: 1

Related medicine news :

1. Chickens Found To Have High Levels of Arsenic
2. Arsenic poisoning reactions can be traced to genes
3. Arsenic in drinking water
4. Arsenic in Drinking Water Predisposes Children To Lung Cancer in Later Life
5. Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc
6. Arsenic Compound Effective in Treating Rare Leukemia
7. Arsenic in Chicken Feed may Cause Health Complications
8. PET Scan find the Area of Brain Responsible for Anorexia Nervosa
9. Gene That Might Be Responsible For Aging
10. Enzyme Responsible For Congenital Blindness
11. New Virus Held Responsible For Respiratory Infection In Children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water is excited to ... water brand owners that topped the list as a result of their commitment to ... premier brand was Tibet 5100, a top notch water company that specializes in providing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 ... more than 200 of the country’s top healthcare executives to share insights on ... benefit of the Forum is the provider-centric perspective, experience, expertise and strategy shared ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience ... across their network of laboratory service centers across the country. Launched in April of ... in the detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... the Ohio Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's ... Convention Center. , As the longest running and largest worker's compensation event ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... February 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm | ... | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: http://www.facebook.com/uspolesportsfederation ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)...  Resolve Therapeutics, LLC, a clinical stage biopharmaceutical ... treatment of lupus and Sjogrens syndrome, today announced ... study in patients with systemic lupus erythematosus (SLE) ... --> --> Data from a ... of RSLV-132 in 32 subjects with SLE demonstrate ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... A Worldwide Clinical Trials expert will present at ... Plaza in London , 24-25 February 2016. ... advances for late phase research on Wednesday, 24 Feb at ... director of project management at Worldwide, will focus on how ... standards in late phase research. --> ...
Breaking Medicine Technology: